We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ABMB:MYXAlliance Bank Malaysia Bhd. Analysis

Data as of 2026-07-18 - not real-time

$0.05

Latest Price

8/10Risk

Risk Level: High

Executive Summary

ABMB is trading at $0.05, sitting below its 20‑day (0.0505), 50‑day (0.0576) and 200‑day (0.0665) simple moving averages, signaling a clear bearish price environment. The 14‑day RSI at 39 suggests modest oversold pressure, while the MACD line has turned marginally bullish against its signal, yet both remain in negative territory. Volume has been on a downtrend, and the 30‑day volatility of roughly 120% combined with a beta of 1.65 points to a highly erratic price profile.
Fundamentally, the company is in distress: revenue is flat at $12.8 M, gross margin is a staggering –99 % and operating margin –84 %, resulting in a net loss of over $1.6 M per share. Operating and free cash flows are deeply negative, and total debt ($36.8 M) exceeds cash on hand ($14.8 M), leaving a negative book value per share and a price‑to‑book ratio of –35. The price‑to‑sales multiple of 4.7 appears unjustified given the lack of earnings, and the stock pays no dividend.
With the market sentiment in the “Extreme Greed” zone (fear‑greed index 87.9) and a historical max drawdown of –50 %, the upside potential is limited unless a material discovery or financing event materializes. Investors should therefore treat ABMB as a high‑risk speculative play rather than a reliable income or value investment.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Price below all major moving averages
  • Decreasing volume and high volatility
  • Negative earnings and cash flow

Medium Term

1–3 years
Neutral
Model confidence: 4/10

Key Factors

  • Potential upside from exploration assets
  • Continued financial distress
  • Uncertain financing prospects

Long Term

> 3 years
Cautious
Model confidence: 3/10

Key Factors

  • Persistent negative margins and debt overhang
  • No dividend or earnings recovery in sight
  • High beta and historical drawdown risk

Key Metrics & Analysis

Financial Health

Profit Margin-164.76%
ROA-33.65%
P/B Ratio-35.1
Op. Cash Flow$-26442300
Free Cash Flow$-36219848

Technical Analysis

TrendBearish
RSI39.1
Support$0.05
Resistance$0.06
MA 20$0.05
MA 50$0.06
MA 200$0.07
MACDBullish
VolumeDecreasing
Fear & Greed Index87.91

Valuation

GradeOvervalued
TypeValue

Risk Assessment

Beta1.65
Volatility119.78%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.